# Evolution of Corporeal Composition in the PeriOperative Period

> **NCT02143869** · — · COMPLETED · sponsor: **Hôpital Européen Marseille** · enrollment: 374 (actual)

## Conditions studied

- Gastrointestinal Cancer (Esophagus, Gastric, Pancreatic, Hepatic, Colorectal and Anal)
- Lung Cancer

## Interventions

- **DEVICE:** Bioelectrical Impedance Analysis

## Key facts

- **NCT ID:** NCT02143869
- **Lead sponsor:** Hôpital Européen Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-12
- **Final completion:** 2019-09
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02143869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02143869, "Evolution of Corporeal Composition in the PeriOperative Period". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02143869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*